Cullinan Therapeutics, Inc.
Recent Filings
All 428 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 10-K | 10-K | Mar 10, 2026 |
| S-8 | S-8 | Mar 10, 2026 |
| 8-K | 8-K | Mar 10, 2026 |
| 4 | 4 | Mar 9, 2026 |
| 144 | — | Mar 5, 2026 |
| SCHEDULE 13G | — | Mar 4, 2026 |
| 4 | 4 | Feb 26, 2026 |
| 4 | 4 | Feb 25, 2026 |
| 4 | 4 | Feb 25, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| AHMED NADIM | President and CEO | Sale | 9,922 @ $10.01 | Dec 23, 2025 |
| Michaelson Jennifer | Chief Scientific Officer | Sale | 1,345 @ $10.01 | Dec 19, 2025 |
| SUMER JACQUELYN L | Chief Legal Officer | Sale | 3,480 @ $9.67 | Dec 18, 2025 |
| Jones Jeffrey Alan | Chief Medical Officer | Sale | 4,632 @ $9.67 | Dec 18, 2025 |
| Michaelson Jennifer | Chief Scientific Officer | Sale | 2,898 @ $9.67 | Dec 18, 2025 |
| Michaelson Jennifer | Chief Scientific Officer | Sale | 2,148 @ $12.38 | Dec 15, 2025 |
| Michaelson Jennifer | Chief Scientific Officer | Sale | 4,000 @ $12.30 | Nov 24, 2025 |
| Nichols Weston | — | Purchase | 165,667 @ $8.40 | Oct 28, 2025 |
| Lynx1 Capital Management LP | — | Purchase | 15,032 @ $7.59 | Oct 15, 2025 |
| Lynx1 Capital Management LP | — | Purchase | 277,298 @ $7.36 | Oct 8, 2025 |